• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Acute Disease

Acute Disease - 176 Studies Found

Completed : S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia
:
  • Acute Leukemias of Ambiguous Lineage
  • B-cell Adult Acute Lymphoblastic Leukemia
  • : 2013-08-15
    :
    • Drug: cyclophosphamide Given I

Completed : A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
:
  • Lymphoblastic Leukemia, Acute, Childhood
  • Myelogenous Leukemia, Acute, Childhood

: 2013-05-21
:
  • Drug: Azacytidine Dose assigne

Active, not recruiting : Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
:
  • Chronic Obstructive Pulmonary Disease
  • COPD
  • Chronic Bronchi
    : 2013-02-08
    : Other: Inhaled 7% HS (NaCl) home treatment Administering inhaled 7% NaCl for two weeks of home treatment
Completed : A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
:
  • Lymphoblastic Leukemia, Acute, Childhood
  • Myelogenous Leukemia, Acute, Childhood

: 2011-08-01
:
  • Drug: AC220 Dose assigned at s

Withdrawn : Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis
:
  • Pulmonary Disease, Chronic Obstructive
  • Bronchitis, Chronic

: 2008-07-30
: Drug: BIBW 2948 BS 7.5 mg b.i.d, 15mg q.d, 15mg b.i.d
Completed : A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
:
  • Pulmonary Disease, Chronic Obstructive
  • Bronchitis, Chronic

: 2002-05-06
: Drug: ABX-IL8
Completed : Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution
:
  • Bronchitis
  • Cough
  • Sputum, Cellular Atypia
  • Acute Lymphoblastic Leukemia in Complete Remission
  • Lymphoblastic Lymphoma in Complete Remiss
    : 2015-09-30
    : Drug: Ixazomib Patients who have been on stable doses of 6 - MP, vincristine, and methotrexate for a min
Recruiting : High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
:
  • Acute Leukemia of Ambiguous Lineage
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • : 2015-08-25
    :
    • Other: Chemosensitivity Assay

Terminated : Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
:
  • Relapsed or Refractory Acute Lymphoblastic Leukemia
  • Relapsed or Refractory Lymphoblastic Lym
    : 2013-06-05
    :
    • Drug: MLN9708
    • Drug: Vincristine

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.